Report
Cor Kluis

Ageas : Q3 impact by VIR and equity impairments, further it is quite stable, S2 rising

>Conclusion: Q3 impact by VIR and equity impairments, S2 ratio rising - For 3Q22 we expect for Ageas an insurance net result of € 238m incl. a negative China interest rate related VIR (€ -70m), incl. a negative capital impairment by declining equity markets (€ -37m), incl. a non-cash accounting gain on the increase of an Indian equity stake (€ +50m). Excluding all these items the life result and Continental European non life results are good. Main earnings pressure is...
Underlying
Ageas SA/NV

Ageas is an insurance company engaged in providing a range of life and non-life products distributed through a variety of channels. Co. focuses on helping its customers to mitigate risks related to property, casualty, life and pensions. Co. serves its customers through a combination of wholly owned subsidiaries, equity associates and partnerships, with financial institutions and distributors in Belgium, the U.K., Luxembourg, Italy, Portugal, Turkey, France, China, Malaysia, India, Thailand and Hong Kong. Co. is organized into five operating segments: Belgium, U.K., Continental Europe, Asia, and General Account.

Provider
Oddo BHF
Oddo BHF

​Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.

Analysts
Cor Kluis

Other Reports on these Companies
Other Reports from Oddo BHF

ResearchPool Subscriptions

Get the most out of your insights

Get in touch